
Dale R. Miller
Examiner (ID: 5360, Phone: (571)272-6146 , Office: P/1673 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1623, 1673, 1693 |
| Total Applications | 838 |
| Issued Applications | 502 |
| Pending Applications | 84 |
| Abandoned Applications | 276 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18468809
[patent_doc_number] => 20230203091
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-29
[patent_title] => GLYCOCONJUGATION PROCESS
[patent_app_type] => utility
[patent_app_number] => 18/176631
[patent_app_country] => US
[patent_app_date] => 2023-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17813
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -96
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18176631
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/176631 | Glycoconjugation process | Feb 28, 2023 | Issued |
Array
(
[id] => 18496109
[patent_doc_number] => 20230218653
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => PTEN INHIBITORS FOR TREATMENT AND PREVENTION OF BONE MARROW LOSS
[patent_app_type] => utility
[patent_app_number] => 18/174989
[patent_app_country] => US
[patent_app_date] => 2023-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12438
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18174989
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/174989 | PTEN inhibitors for treatment and prevention of bone marrow loss | Feb 26, 2023 | Issued |
Array
(
[id] => 18524193
[patent_doc_number] => 20230234850
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-27
[patent_title] => ADJUVANTED VACCINES
[patent_app_type] => utility
[patent_app_number] => 18/172695
[patent_app_country] => US
[patent_app_date] => 2023-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19078
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18172695
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/172695 | ADJUVANTED VACCINES | Feb 21, 2023 | Abandoned |
Array
(
[id] => 18451212
[patent_doc_number] => 20230192489
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => ADJUVANTED VACCINES
[patent_app_type] => utility
[patent_app_number] => 18/172624
[patent_app_country] => US
[patent_app_date] => 2023-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19079
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18172624
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/172624 | ADJUVANTED VACCINES | Feb 21, 2023 | Abandoned |
Array
(
[id] => 18449667
[patent_doc_number] => 20230190943
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => ALGINIC ACID DERIVATIVE BONDED TO NONSTEROIDAL ANTI-INFLAMMATORY COMPOUND
[patent_app_type] => utility
[patent_app_number] => 18/163650
[patent_app_country] => US
[patent_app_date] => 2023-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28647
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18163650
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/163650 | ALGINIC ACID DERIVATIVE BONDED TO NONSTEROIDAL ANTI-INFLAMMATORY COMPOUND | Feb 1, 2023 | Abandoned |
Array
(
[id] => 18610844
[patent_doc_number] => 20230277574
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-07
[patent_title] => TREATMENT OF HEARING LOSS
[patent_app_type] => utility
[patent_app_number] => 18/154474
[patent_app_country] => US
[patent_app_date] => 2023-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25457
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18154474
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/154474 | Treatment of hearing loss | Jan 12, 2023 | Issued |
Array
(
[id] => 18483580
[patent_doc_number] => 20230210878
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-06
[patent_title] => FORMULATIONS AND METHODS FOR TREATING CONDITIONS OF THE EYE
[patent_app_type] => utility
[patent_app_number] => 18/088347
[patent_app_country] => US
[patent_app_date] => 2022-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21296
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18088347
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/088347 | Formulations and methods for treating conditions of the eye | Dec 22, 2022 | Issued |
Array
(
[id] => 18434320
[patent_doc_number] => 20230181614
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => ADMINISTRATION OF CITICOLINE TO IMPROVE COGNITIVE PERFORMANCE, ATTENTIONAL PERFORMANCE, AND MOTOR FUNCTION
[patent_app_type] => utility
[patent_app_number] => 18/069325
[patent_app_country] => US
[patent_app_date] => 2022-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22960
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18069325
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/069325 | Administration of citicoline to improve cognitive performance, attentional performance, and motor function | Dec 20, 2022 | Issued |
Array
(
[id] => 18322538
[patent_doc_number] => 20230120666
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-20
[patent_title] => EXCIPIENTS PROVIDING STABILIZATION AND ENHANCED WATER SOLUBILIZATION AND THEIR USES
[patent_app_type] => utility
[patent_app_number] => 18/082566
[patent_app_country] => US
[patent_app_date] => 2022-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24389
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18082566
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/082566 | EXCIPIENTS PROVIDING STABILIZATION AND ENHANCED WATER SOLUBILIZATION AND THEIR USES | Dec 14, 2022 | Pending |
Array
(
[id] => 18361321
[patent_doc_number] => 20230142912
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => PERITONEAL DIALYSIS SOLUTION
[patent_app_type] => utility
[patent_app_number] => 18/078764
[patent_app_country] => US
[patent_app_date] => 2022-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13979
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18078764
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/078764 | Peritoneal dialysis solution | Dec 8, 2022 | Issued |
Array
(
[id] => 18824361
[patent_doc_number] => 11839625
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-12-12
[patent_title] => Application of low-molecular-weight hyaluronic acid (LMW-HA) fragments
[patent_app_type] => utility
[patent_app_number] => 18/073604
[patent_app_country] => US
[patent_app_date] => 2022-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 14
[patent_no_of_words] => 23412
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 133
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18073604
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/073604 | Application of low-molecular-weight hyaluronic acid (LMW-HA) fragments | Dec 1, 2022 | Issued |
Array
(
[id] => 18792647
[patent_doc_number] => 11826380
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-11-28
[patent_title] => Application of low-molecular-weight hyaluronic acid (LMW-HA) fragments
[patent_app_type] => utility
[patent_app_number] => 18/073596
[patent_app_country] => US
[patent_app_date] => 2022-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 15
[patent_no_of_words] => 23444
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18073596
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/073596 | Application of low-molecular-weight hyaluronic acid (LMW-HA) fragments | Dec 1, 2022 | Issued |
Array
(
[id] => 18336785
[patent_doc_number] => 20230128734
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-27
[patent_title] => Application of Low-Molecular-Weight Hyaluronic Acid (LMW-HA) Fragments
[patent_app_type] => utility
[patent_app_number] => 18/073601
[patent_app_country] => US
[patent_app_date] => 2022-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23425
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18073601
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/073601 | Application of low-molecular-weight hyaluronic acid (LMW-HA) fragments | Dec 1, 2022 | Issued |
Array
(
[id] => 18930983
[patent_doc_number] => 11883377
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-01-30
[patent_title] => Algal botanical extracts rich in eicosapentaenoic acid as tri/di-glyceride conjugate
[patent_app_type] => utility
[patent_app_number] => 17/994014
[patent_app_country] => US
[patent_app_date] => 2022-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4018
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17994014
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/994014 | Algal botanical extracts rich in eicosapentaenoic acid as tri/di-glyceride conjugate | Nov 24, 2022 | Issued |
Array
(
[id] => 18323946
[patent_doc_number] => 20230122074
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-20
[patent_title] => FOOD COMPOSITION FOR AMELIORATING CEREBROVASCULAR DISEASES CONTAINING 2'-FUCOSYLLACTOSE AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CEREBROVASCULAR DISEASES CONTAINING 2'-FUCOSYLLACTOSE
[patent_app_type] => utility
[patent_app_number] => 17/993770
[patent_app_country] => US
[patent_app_date] => 2022-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4674
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17993770
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/993770 | Food composition for ameliorating cerebrovascular diseases containing 2'- fucosyllactose and pharmaceutical composition for preventing or treating cerebrovascular diseases containing 2'-fucosyllactose | Nov 22, 2022 | Issued |
Array
(
[id] => 18265671
[patent_doc_number] => 20230086913
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => USE OF SOPHOROLIPIDS AS FEED ADDITIVE
[patent_app_type] => utility
[patent_app_number] => 17/984770
[patent_app_country] => US
[patent_app_date] => 2022-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9299
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17984770
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/984770 | USE OF SOPHOROLIPIDS AS FEED ADDITIVE | Nov 9, 2022 | Abandoned |
Array
(
[id] => 19674493
[patent_doc_number] => 12186331
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-01-07
[patent_title] => Compositions comprising at least one n-acetylated and at least one fucosylated oligosaccharide for use in the promotion of digestive capacity in infants and young children
[patent_app_type] => utility
[patent_app_number] => 17/983992
[patent_app_country] => US
[patent_app_date] => 2022-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10529
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17983992
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/983992 | Compositions comprising at least one n-acetylated and at least one fucosylated oligosaccharide for use in the promotion of digestive capacity in infants and young children | Nov 8, 2022 | Issued |
Array
(
[id] => 18468802
[patent_doc_number] => 20230203084
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-29
[patent_title] => SENSITIVE OLIGONUCLEOTIDE SYNTHESIS USING SULFUR-BASED FUNCTIONS AS PROTECTING GROUPS AND LINKERS
[patent_app_type] => utility
[patent_app_number] => 17/978214
[patent_app_country] => US
[patent_app_date] => 2022-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18168
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17978214
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/978214 | Sensitive oligonucleotide synthesis using sulfur-based functions as protecting groups and linkers | Oct 31, 2022 | Issued |
Array
(
[id] => 18237926
[patent_doc_number] => 20230070236
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-09
[patent_title] => METHOD AND COMPOSITION FOR IMPROVED HYDRATION IN ANIMALS
[patent_app_type] => utility
[patent_app_number] => 17/977034
[patent_app_country] => US
[patent_app_date] => 2022-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17564
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17977034
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/977034 | METHOD AND COMPOSITION FOR IMPROVED HYDRATION IN ANIMALS | Oct 30, 2022 | Pending |
Array
(
[id] => 19682304
[patent_doc_number] => 20250000849
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-02
[patent_title] => COMPOSITE COMPOSITION CONTAINING ANGIOTENSIN RECEPTOR BLOCKER AND SGLT2 INHIBITOR
[patent_app_type] => utility
[patent_app_number] => 18/704685
[patent_app_country] => US
[patent_app_date] => 2022-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6027
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18704685
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/704685 | COMPOSITE COMPOSITION CONTAINING ANGIOTENSIN RECEPTOR BLOCKER AND SGLT2 INHIBITOR | Oct 26, 2022 | Pending |